{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:19:33Z","timestamp":1765441173662,"version":"3.46.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Nursing"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jvn.2025.07.008","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T19:04:53Z","timestamp":1754766293000},"page":"181-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Prospective comparative study on analyzing the potency of mono antiplatelet therapy versus dual antiplatelet therapy in optimizing the recurrence of secondary vascular events"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8304-5496","authenticated-orcid":false,"given":"Chinmai","family":"Anugula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0816-5682","authenticated-orcid":false,"given":"Suhana Begum","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2768-357X","authenticated-orcid":false,"given":"Rajavardhana","family":"Thamineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8036-8426","authenticated-orcid":false,"given":"Sasidhar Reddy","family":"Gangarapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shireesha","family":"Palle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvn.2025.07.008_sbref0001","article-title":"What is blood vessel disease? [Internet]","author":"Heidi Moawad","year":"2023","journal-title":"Very Well Health"},{"issue":"6","key":"10.1016\/j.jvn.2025.07.008_bib0002","first-page":"265","article-title":"Medical management of risk factors for vascular disease","volume":"36","author":"Sharkey","year":"2018","journal-title":"Surg(Oxf)"},{"issue":"36","key":"10.1016\/j.jvn.2025.07.008_bib0003","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.jvn.2025.07.008_bib0004","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the Management of lower extremity peripheral artery Disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jvn.2025.07.008_bib0005","unstructured":"Cesare M.D.D. World heart report 2023 - World Heart Federation [Internet]. 2023 [cited 2023 Dec 19]. Available from: https:\/\/world-heart-federation.org\/wp-content\/uploads\/World-Heart-Report-2023.pdf."},{"issue":"8","key":"10.1016\/j.jvn.2025.07.008_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 Heart Disease and Stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jvn.2025.07.008_bib0007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0028-3886.178042","article-title":"ASAP. Stroke burden and stroke care system in Asia","volume":"64","author":"Suwanwela","year":"2016","journal-title":"Neurol India"},{"issue":"10","key":"10.1016\/j.jvn.2025.07.008_bib0008","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: asystematic analysis for the Global Burden of Disease Study 2021","volume":"23","author":"Feigin","year":"2024","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.jvn.2025.07.008_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.120.028992","article-title":"Risk and secondary prevention of stroke recurrence","volume":"51","author":"Flach","year":"2020","journal-title":"Stroke"},{"issue":"42","key":"10.1016\/j.jvn.2025.07.008_bib0010","first-page":"711","article-title":"The frequency and timing of recurrent stroke: an analysis of routine health insurance data","volume":"116","author":"Stahmeyer","year":"2019","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"10.1016\/j.jvn.2025.07.008_bib0011","first-page":"152","article-title":"Therapeutic use of antiplatelet agents","volume":"16","author":"Halim","year":"2016","journal-title":"Clin Med (L)"},{"key":"10.1016\/j.jvn.2025.07.008_bib0012","doi-asserted-by":"crossref","unstructured":"Dong J., Wang F., Sundararajan S. Use of dual antiplatelet therapy following ischemic stroke.Stroke. 2020 May;51(5).","DOI":"10.1161\/STROKEAHA.119.028400"},{"issue":"6","key":"10.1016\/j.jvn.2025.07.008_bib0013","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1161\/STROKEAHA.120.033033","article-title":"Dual antiplatelet therapy versus aspirin in patients with stroke or transient ischemic attack: meta-analysis of randomized controlled trials","volume":"52","author":"Bhatia","year":"2021","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jvn.2025.07.008_bib0014","first-page":"1975","article-title":"Antiplatelet use in ischemic stroke","volume":"56","author":"Kamarova","year":"2022","journal-title":"Ann Pharmacother [Internet]"},{"issue":"2","key":"10.1016\/j.jvn.2025.07.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13579","article-title":"Antiplatelet treatment patterns and outcomes of secondary stroke prevention in the United States","volume":"9","author":"O'Brien","year":"2023","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.jvn.2025.07.008_bib0016","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.022","article-title":"A comparative study of dual versus Mono antiplatelet therapy in patients with acute large-artery atherosclerosis stroke","volume":"23","author":"Yi","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.jvn.2025.07.008_bib0017","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036915","article-title":"al.Clinical recurrence and antiplatelet drug resistance among patients with lower limb ischemia","volume":"103","author":"Alrabadi","year":"2024","journal-title":"Med (Baltim)"},{"issue":"25","key":"10.1016\/j.jvn.2025.07.008_bib0018","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1161\/CIRCULATIONAHA.121.053782","article-title":"Efficacy and safety of using dual versus monotherapy antiplatelet agents in secondary stroke prevention: systematic review and meta-analysis of randomized controlled clinical trials","volume":"143","author":"Trifan","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jvn.2025.07.008_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/STR.0000000000000377","article-title":"Benefits and risks of dual versus single antiplatelet therapy for secondary stroke prevention: a systematic review for the 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack","author":"Brown","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jvn.2025.07.008_bib0020","doi-asserted-by":"crossref","unstructured":"Bouget J., Balusson F., Viglino D., Roy P.M., Lacut K., Pavageau L., et al. Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study. Paul T, editor. PLoS One. 2020 Aug 7;15(8):e0237022.","DOI":"10.1371\/journal.pone.0237022"},{"issue":"7","key":"10.1016\/j.jvn.2025.07.008_bib0021","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/bcp.14193","article-title":"The Medication Adherence Report Scale: a measurement tool for eliciting patients' reports of nonadherence","volume":"86","author":"Chan","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jvn.2025.07.008_bib0022","first-page":"220","article-title":"Comparative effectiveness of dual antiplatelet therapy versus monotherapy in patients with ischemic stroke","volume":"28","author":"Algarni","year":"2023","journal-title":"Neurosci [Internet]"},{"issue":"11","key":"10.1016\/j.jvn.2025.07.008_bib0023","article-title":"Comparative effectiveness of dual antiplatelet therapy with Aspirin and Clopidogrel versus Aspirin monotherapy in mild- to- moderate acute ischemic stroke according to the risk of recurrent stroke","volume":"13","author":"Lee","year":"2020","journal-title":"Circ: Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jvn.2025.07.008_bib0024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.alcohol.2020.02.166","article-title":"Alcohol-induced thrombocytopenia: current review","volume":"86","author":"Silczuk","year":"2020","journal-title":"Alcohol"}],"container-title":["Journal of Vascular Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1062030325000779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1062030325000779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:13:34Z","timestamp":1765440814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1062030325000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1062030325000779"],"URL":"https:\/\/doi.org\/10.1016\/j.jvn.2025.07.008","relation":{},"ISSN":["1062-0303"],"issn-type":[{"type":"print","value":"1062-0303"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Prospective comparative study on analyzing the potency of mono antiplatelet therapy versus dual antiplatelet therapy in optimizing the recurrence of secondary vascular events","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvn.2025.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Vascular Nursing, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}